Truist Securities Initiates Coverage On Ovintiv with Buy Rating, Announces Price Target of $70

Benzinga Newsdesk www.benzinga.com Positive 70.6%

Neg 0% Neu 0% Pos 70.6%

Truist Securities analyst Gabe Daoud initiates coverage on Ovintiv (NYSE:OVV) with a Buy rating and announces Price Target of $70.